COMPANY PROFILE

Anadys

Explore full profile

Innovative pharmaceutical solutions targeting unmet medical needs in infectious diseases and oncology

San Diego, United StatesFounded 2000Biotechnology

Valuation $100–250M Last recorded · 2009

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Anadys

Anadys Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for infectious diseases and cancer. The company operates in the pharmaceutical industry, targeting both healthcare providers and patients as its primary clients. Anadys Pharmaceuticals employs a research-driven business model, investing heavily in the development of new drugs and therapies. Revenue is generated through the sale of these pharmaceutical products, as well as through partnerships and licensing agreements with other healthcare companies. The company aims to address significant gaps in the treatment of infectious diseases and oncology, providing advanced solutions that improve patient outcomes.

MoreLess Source: Dealroom company data

At a glance

Status: Closed
Founded: 2000
Headquarters: San Diego, United States
Employees: 10
Open positions: None listed
Dealroom signal: 0.0/100
Sector: Biotechnology
Client focus: b2c
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Jun 2009	$18M	$70M	Undisclosed	—
IPO✓Exit	Mar 2004	$0	—	Undisclosed	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Anadys website traffic

Latest recorded traffic for Anadys is 0 monthly website visits. Anadys's team declined 47.4% over the past year.

Latest monthly visits0 1-year team growth-47.4%

Monthly website visitsMay 2017–Dec 2019

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MRMyClinic RigaHome - My Clinic Riga	Latvia	Operational	6	—	—
SISardinia InnovationA weight-loss supplement called w-loss	Italy	Operational
HMHB Custom MediaSupplier of custom tissue culture media, reagents, supplements	Bethlehem, United States	Acquired
OTOmniActive Health TechnologiesOmniActive was born from Kancor Ingredients, an ingredient supplier rooted in the food and flavoring industry	Morristown, United States	Acquired
WTWise Ape TeaA brand built for a new generation of tea drinkers	United States	Operational
LELife EqualsCreators of Balance the Superfood Shot. Our delicious superfood shot delivers 1/2 your daily organic superfoods in a convenient 2oz shot	Lenexa, United States	Operational
BIBioTorkBiotechnology company focusing on sustainability through the development of microbial strains and bioconversion processes	Gainesville, United States	Operational
BJBetter JuiceBetter Juice develops a method for reducing sugars in fruit juice by converting them into nondigestible forms, including dietary fibers such as fructooligosaccharide (FOS) and other nondigestible molecules, without altering the natural flavor or smel	Haifa, Israel	Acquired